Ashish M. Kamat: Deintensification of Treatment for Low-grade Bladder Tumors
Ashish M. Kamat posted on X about recent paper by Roberto Contieri et al., titled “Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)” published on Science Direct.
Authors: Roberto Contieri, Mark S. Soloway, Paolo Gontero, Harry Herr, Wassim Kassouf, Laura S. Mertens, Marco Moschini, Michael O’Donnell, Joan Palou, Sarah P. Psutka, Morgan Rouprêt, Jeremy Y.C. Teoh, Ashish M. Kamat.
“Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)”
Source: Ashish M. Kamat/X
Ashish M. Kamat is the Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD Anderson Cancer Center. He is also President of the International Bladder Cancer Group (IBCG) and International Bladder Cancer Network (IBCN).
He is Associate Editor for European Urology Oncology, Editor for the UroToday Bladder Cancer Center of Excellence, directed the MDACC Urologic Oncology Fellowship from 2005-2016, and is an alumnus of the AUA Leadership Program.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023